100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
Previously searched by you
TEST BANK FOR PHARMACOLOGY: A PATIENT-CENTERED NURSING PROCESS APPROACH, 11TH EDITION BY MCCUISTION WITH VERIFIED QUESTIONS AND ANSWERS£15.94
Add to cart
Test Bank For Pharmacology A Patient-Centered Nursing Process Approach 11th Edition by Linda E. McCuistion, Kathleen Vuljoin DiMaggio, Mary B. Winton, Jennifer J. Yeager |All Chapters, Year-2025|
Test Bank Pharmacology A Patient-Centered Nursing Process Approach, 11th Edition by Linda E. McCuistion || All Chapters || Complete Solution | Grade A+.
Test Bank For Pharmacology A Patient-Centered Nursing Process Approach 11th Edition by Linda E. McCuistion, Kathleen Vuljoin DiMaggio, Mary B. Winton, Jennifer J. Yeager |All Chapters, Year-2024-2025 ...
All for this textbook (78)
Written for
PHARMACOLOGY: A PATIENT-CENTERED NURSING PROCESS
PHARMACOLOGY: A PATIENT-CENTERED NURSING PROCESS
Seller
Follow
AchieveQualityGrades01
Reviews received
Content preview
TEST BANK FOR
PHARMACOLOGY:
A PATIENT-CENTERED NURSING PROCESS
APPROACH, 11TH EDITION BY MCCUISTION
WITH VERIFIED QUESTIONS AND ANSWERS
, TABLE OF CONTENTS
CHAPTER 01: THE NURSING PROCESS AND PATIENT-CENTERED CARE ........................................................ 4
CHAPTER 02: DRUG DEVELOPMENT AND ETHICAL CONSIDERATIONS ...................................................... 10
CHAPTER 03: PHARMACOKINETICS, PHARMACODYNAMICS, AND PHARMACOGENETICS
MCCUISTION: PHARMACOLOGY: A PATIENT- CENTERED NURSING PROCESS APPROACH,
11THEDITION .................................................................................................................................................................... 19
CHAPTER 04: PHARMACOGENETICS ........................................................................................................................ 34
CHAPTER 05: COMPLEMENTARY AND ALTERNATIVE THERAPIES ............................................................... 37
CHAPTER 06: PEDIATRIC CONSIDERATIONS ......................................................................................................... 41
CHAPTER 07: GERIATRIC CONSIDERATIONS ........................................................................................................ 50
CHAPTER 08: DRUGS OF ABUSE .................................................................................................................................. 56
CHAPTER 09: SAFETY AND QUALITY ....................................................................................................................... 63
CHAPTER 10: DRUG ADMINISTRATION.................................................................................................................... 69
CHAPTER 11: DRUG CALCULATIONS ........................................................................................................................ 74
CHAPTER 12: FLUID VOLUME AND ELECTROLYTES........................................................................................... 79
CHAPTER 13: VITAMIN AND MINERAL REPLACEMENT ..................................................................................... 88
CHAPTER 14: NUTRITIONAL SUPPORT .................................................................................................................... 96
CHAPTER 15: ADRENERGIC AGONISTS AND ANTAGONISTS ................................................................................ 105
CHAPTER 16: CHOLINERGIC AGONISTS AND ANTAGONISTS ......................................................................... 110
CHAPTER 17: STIMULANTS ........................................................................................................................................ 117
CHAPTER 18: DEPRESSANTS ...................................................................................................................................... 121
CHAPTER 19: ANTISEIZURE DRUGS ........................................................................................................................ 127
CHAPTER 20: DRUGS FOR PARKINSON DISEASE AND ALZHEIMER DISEASE ........................................... 134
CHAPTER 21: DRUGS FOR NEUROMUSCULAR DISORDERS AND MUSCLE SPASMS MCCUISTION:
PHARMACOLOGY: A PATIENT- CENTERED NURSING PROCESS APPROACH, 11THEDITION .............. 140
CHAPTER 22: ANTIPSYCHOTICS AND ANXIOLYTICS ........................................................................................ 146
CHAPTER 23: ANTIDEPRESSANTS AND MOOD STABILIZERS ......................................................................... 153
CHAPTER 24: ANTIINFLAMMATORIES................................................................................................................... 160
CHAPTER 25: ANALGESICS ......................................................................................................................................... 168
CHAPTER 26: ANTIBACTERIALS .............................................................................................................................. 174
CHAPTER 27: ANTITUBERCULARS, ANTIFUNGALS, AND ANTIVIRALS ....................................................... 191
CHAPTER 28: PEPTIDES, ANTIMALARIALS, AND ANTHELMINTICS ............................................................. 199
CHAPTER 29: HIV- AND AIDS-RELATED DRUGS .................................................................................................. 202
CHAPTER 30: TRANSPLANT DRUGS ......................................................................................................................... 207
CHAPTER 31: VACCINES .............................................................................................................................................. 210
CHAPTER 32: ANTICANCER DRUGS......................................................................................................................... 214
CHAPTER 33: TARGETED THERAPIES TO TREAT CANCER .............................................................................. 218
CHAPTER 34: BIOLOGIC RESPONSE MODIFIERS ................................................................................................ 221
CHAPTER 35: UPPER RESPIRATORY DISORDERS ............................................................................................... 225
CHAPTER 36: LOWER RESPIRATORY DISORDERS ............................................................................................. 229
CHAPTER 37: CARDIAC GLYCOSIDES, ANTIANGINALS, AND ANTIDYSRHYTHMICS MCCUISTION:
, CHAPTER 01: THE NURSING PROCESS AND PATIENT-CENTERED
CARE
MCCUISTION: PHARMACOLOGY: A PATIENT-CENTERED NURSING
PROCESS APPROACH, 11THEDITION
MULTIPLE CHOICE
1. THE NURSING PROCESS IS A FIVE-STEP DECISION-MAKING
APPROACH THAT INCLUDES ALL OF THEFOLLOWING STEPS, EXCEPT:
A. ASSESSMENT
b. PATIENT PROBLEM
c. PLANNING
d. RIGHT DRUG
ANS: D
THE NURSING PROCESS IS A FIVE-STEP DECISION-MAKING APPROACH THAT
INCLUDES: 1) ASSESSMENT, 2) PATIENT PROBLEM, 3) PLANNING, 4)
IMPLEMENTATION, AND 5) EVALUATION. ―RIGHT DRUG‖ IS ONE OF THE
―SIX RIGHTS‖ OF MEDICATION ADMINISTRATION.
DIF: COGNITIVE LEVEL: UNDERSTANDING (COMPREHENSION) TOP: NURSING
PROCESS: PLANNING MSC:NCLEX: MANAGEMENT OF CARE
2. THE NURSE IS USING DATA COLLECTED TO SET GOALS OR EXPECTED
OUTCOMES AND INTERVENTIONS THAT ADDRESS THE PATIENT‘S
PROBLEMS. WHICH STEP OF THE NURSING PROCESS IS THE NURSE
APPLYING? A.
ASSESSMENT
b. PATIENT PROBLEM
c. PLANNING
d. EVALUATION
ANS: C
DURING THE PLANNING PHASE, THE NURSE USES THE DATA COLLECTED TO
SET GOALS OR EXPECTED OUTCOMES AND INTERVENTIONS WHICH ADDRESS
THE PATIENT‘S PROBLEMS. THE DATA WAS COLLECTED DURING THE
―ASSESSMENT‖ AND ―PATIENT PROBLEM‖ STEPS. DURING THE
―EVALUATION‖ PHASE THENURSE WOULD DETERMINE WHETHER THE
GOALS AND OBJECTIVES SET DURING THE PLANNING PHASE WERE MET.
DIF: COGNITIVE LEVEL: UNDERSTANDING
(COMPREHENSION)TOP: NURSING PROCESS:
NURSING INTERVENTION MSC:
NCLEX: MANAGEMENT OF CARE
3. A 5-YEAR-OLD CHILD WITH TYPE 1 DIABETES MELLITUS HAS HAD
REPEATED HOSPITALIZATIONS FOR EPISODES OF HYPERGLYCEMIA. THE
PARENTS TELL THE NURSE THAT THEY CAN‘T KEEP TRACK OF
EVERYTHING THAT HAS TO BE DONE TO CARE FOR THEIR CHILD. THE
NURSE REVIEWS MEDICATIONS, DIET, AND SYMPTOM MANAGEMENT WITH
THE PARENTS AND DRAWS UP A DAILY CHECKLIST FOR THE FAMILY TO
USE. THESE ACTIVITIES ARE COMPLETED IN WHICH STEP OF THE NURSING
PROCESS? A. ASSESSMENT
b. PLANNING
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller AchieveQualityGrades01. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for £15.94. You're not tied to anything after your purchase.
